Cargando…

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Mostrar otras versiones (1)

Equitable access to vaccines is necessary to limit the global impact of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In previous studies, we described the development of a low-cost vaccine based on a...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Domínguez, Irene, Martínez, Jose Luis, Slamanig, Stefan, Lemus, Nicholas, Liu, Yonghong, Lai, Tsoi Ying, Carreño, Juan Manuel, Singh, Gagandeep, Schotsaert, Michael, Mena, Ignacio, McCroskery, Stephen, Coughlan, Lynda, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter, Sun, Weina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241906/ https://www.ncbi.nlm.nih.gov/pubmed/35658571 http://dx.doi.org/10.1128/spectrum.01538-22

Ejemplares similares

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
por: Sun, Weina, et al.
Publicado: (2020)

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
por: Sun, Weina, et al.
Publicado: (2020)

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
por: Sun, Weina, et al.
Publicado: (2021)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
por: Ponce-de-León, Samuel, et al.
Publicado: (2023)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

Myostatin negatively regulates satellite cell activation and self-renewal
por: McCroskery, Seumas, et al.
Publicado: (2003)

Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges
por: Tan, Lei, et al.
Publicado: (2020)

An intranasal recombinant NDV-BRSV F(opt) vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
por: Sacco, Randy E., et al.
Publicado: (2022)

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV
por: Roohani, Kiarash, et al.
Publicado: (2015)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
por: Muñoz-Alía, Miguel Á., et al.
Publicado: (2022)

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
por: Pitisuttithum, Punnee, et al.
Publicado: (2022)

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
por: Carreño, Juan Manuel, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
por: Kubale, John, et al.
Publicado: (2022)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein
por: Chumbe, Ana, et al.
Publicado: (2017)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
por: Ferreira, Helena L., et al.
Publicado: (2021)

RECEPTOR DESTRUCTION BY VIRUSES OF THE MUMPS-NDV-INFLUENZA GROUP
por: Hirst, George K.
Publicado: (1950)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
por: Alqarihi, Abdullah, et al.
Publicado: (2019)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

The effects of different velogenic NDV infections on the chicken bursa of Fabricius
por: Kristeen-Teo, Y. W., et al.
Publicado: (2017)

Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
por: Ding, Ke, et al.
Publicado: (2018)

Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge
por: Sun, Minhua, et al.
Publicado: (2018)

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
por: Singh, Shakti, et al.
Publicado: (2019)

Summary of worldwide pediatric malignancies reported after exposure to etanercept
por: McCroskery, Peter, et al.
Publicado: (2010)

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
por: García-Bernalt Diego, Juan, et al.
Publicado: (2023)

MECHANISM OF PRODUCTION OF PULMONARY LESIONS IN MICE BY NEWCASTLE DISEASE VIRUS (NDV)
por: Ginsberg, Harold S.
Publicado: (1951)

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
por: Lara-Puente, Jesús Horacio, et al.
Publicado: (2021)

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
por: Gold, Ralf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u8epu3kvt5omhfa92kb9c8taod